Cannon Financial Strategists, Inc. Pfizer Inc Transaction History

Cannon Financial Strategists, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 02, 2024	BUY	$32.09 - $37.51 $128,616 - $150,340	4,008 New	4,008 $1.4 Billion
Q1 2022 Oct 02, 2024	SELL	$45.75 - $56.69 $3.74 Million - $4.64 Million	-81,785 Closed	0 $0
Q4 2021 Oct 02, 2024	BUY	$41.32 - $61.25 $3.38 Million - $5.01 Million	81,785 New	81,785 $19.7 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.